ReLive Biotechnologies LTD

About:

ReLive is spearheading regenerative cell therapies to address unmet needs in the areas of orthopedic sports medicine and plastic surgery.

Website: https://www.relivebio.com

Top Investors: Shanghai Healthcare Capital, Jiuyou Capital, Indaco Capital

Description:

ReLive is a biotechnology company that develops orthopedic sports medicine and plastic and reconstructive surgery projects based on regenerative medicine and cell therapy science.

Total Funding Amount:

$50M

Headquarters Location:

Newton, Massachusetts, United States

Founded Date:

2021-06-01

Founders:

Xing Zhao, Ying Zhou

Number of Employees:

51-100

Last Funding Date:

2023-01-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai